Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
Status:
Withdrawn
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This study will determine the safety and applicability of experimental forms of umbilical
cord blood (UCB) transplantation for patients with high risk hematologic malignancies who
might benefit from a hematopoietic stem cell transplant (HSCT) but who do not have a standard
donor option (no available HLA-matched related donor (MRD), HLA-matched unrelated donor
(MUD)), or single UCB unit with adequate cell number and HLA-match).
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey